The safety of robot-assisted surgery versus laparoscopic surgery for rectal tumor patients.

Authors

null

Jesse Yu Tajima

Department of Gastroenterological Surgery, Gifu University Hospital, Gifu, Japan

Jesse Yu Tajima , Ryoma Yokoi , Shigeru Kiyama , Hirokata Hayashi , Toshiya Higashi , Ryuichi Asai , Yoshihiro Tanaka , Naoki Okumura , Katsutoshi Murase , Nobuhisa Matsuhashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies

Sub Track

Other Technology and Innovations

Citation

JCO Global Oncology 9, 2023 (suppl 1; abstr 56)

DOI

10.1200/GO.2023.9.Supplement_1.56

Abstract #

56

Poster Bd #

D3

Abstract Disclosures

Similar Posters

First Author: Pan Chi

First Author: Jianmin Xu

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2.

Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2.

First Author: Thomas J. George